Skip to main content

Drugs Made In America Acquisition II Corp.

corporate_fare Company Profile

Drugs Made In America Acquisition II Corp.

DMII·NASDAQ·Real Estate & Construction·CIK 0002040475

Drugs Made In America Acquisition II Corp. does not currently have significant business operations. The company's primary objective is to complete a business combination, such as a merger, share exchange, asset acquisition, share purchase, recapitalization, or reorganization, with one or more existing businesses. It specifically aims to identify and assess companies operating within the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was established in 2024 and is located in New York, New York.

Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 9 items for DMII at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-14, rated 8/10. Across its 9 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for DMII spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • SPAC Flags Going Concern, Material Weakness, and 35% Discount Convertible Notes
  • SPAC DMII Posts $4.34M Net Income in Q1 2026, Reversing Prior Loss
  • Company Discloses Material Weakness in Internal Controls, Reaffirms Going Concern
  • DMII Formalizes CEO & CFO Compensation with Significant Equity Grants Amid Cash Flow Constraints
  • SPAC Discloses Going Concern, Sponsor Default, CEO Ousting, and Material Weaknesses

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
$4.19M
Op. Cash Flow
-$1.02M
Operating Income
-$488.38K
Cash & Equivalents
$223
Debt / Equity
0.00×
Shares Outstanding
13.7M sh
Source: 10-K · filed 2026-04-15 · accession 0001213900-26-044055
Browse all tickers starting with D →
$10.17 -0.01% today
52-week range · as of 2026-08-14 $9.86 – $10.2
Market cap
$647.83M
Volume
153.6K (2.0× avg)
3-mo avg 75.9K
Live data · 2026-09-21 04:30 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed DMII - Latest Insights

DMII
Aug 14, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
SPAC Flags Going Concern, Material Weakness, and 35% Discount Convertible Notes
Price at Filing: $10.13
Real-time Price: $10.17 info
Change: +$0.040 (+0.39%) info
Market Cap: $647.829M info
Sentiment: Negative
View Wiseek Article
DMII
May 14, 2026, 4:27 PM EDT
Source: Wiseek News
Importance Score:
7
SPAC DMII Posts $4.34M Net Income in Q1 2026, Reversing Prior Loss
Price at Filing: $10.03
Real-time Price: $10.17 info
Change: +$0.140 (+1%) info
Market Cap: $647.829M info
Sentiment: Neutral
View Wiseek Article
DMII
May 14, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
8
Company Discloses Material Weakness in Internal Controls, Reaffirms Going Concern
Price at Filing: $10.03
Real-time Price: $10.17 info
Change: +$0.140 (+1%) info
Market Cap: $647.829M info
Sentiment: Negative
View Wiseek Article
DMII
Apr 28, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
7
DMII Formalizes CEO & CFO Compensation with Significant Equity Grants Amid Cash Flow Constraints
Price at Filing: $10.01
Real-time Price: $10.17 info
Change: +$0.160 (+2%) info
Market Cap: $647.829M info
Sentiment: Negative
View Wiseek Article
DMII
Apr 15, 2026, 4:09 PM EDT
Filing Type: 10-K
Importance Score:
9
SPAC Discloses Going Concern, Sponsor Default, CEO Ousting, and Material Weaknesses
Price at Filing: $10.00
Real-time Price: $10.17 info
Change: +$0.170 (+2%) info
Market Cap: $647.829M info
Sentiment: Negative
View Wiseek Article
DMII
Apr 03, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
DMII Secures $1.4M Financing with 35% Discount Convertible Notes for De-SPAC, Addresses Sponsor Transition
Price at Filing: $9.99
Real-time Price: $10.17 info
Change: +$0.180 (+2%) info
Market Cap: $647.829M info
Sentiment: Negative
View Wiseek Article
DMII
Mar 17, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Secures $150K Bridge Loan, Plans $1.4M Convertible Note Financing with 35% Discount for Business Combination Expenses
Price at Filing: $9.96
Real-time Price: $10.17 info
Change: +$0.210 (+2%) info
Market Cap: $647.829M info
Sentiment: Neutral
View Wiseek Article
DMII
Mar 06, 2026, 5:01 PM EST
Filing Type: 8-K
Importance Score:
8
Trust Account Confirmed Safe with $507M Balance Following Prior Irregularity Disclosure
Price at Filing: $9.94
Real-time Price: $10.17 info
Change: +$0.230 (+2%) info
Market Cap: $647.829M info
Sentiment: Positive
View Wiseek Article
DMII
Mar 06, 2026, 10:10 AM EST
Filing Type: 8-K
Importance Score:
8
CEO Removed Amidst Sponsor's Inability to Repay Over $766K in Misappropriated Funds
Price at Filing: $9.98
Real-time Price: $10.17 info
Change: +$0.190 (+2%) info
Market Cap: $647.829M info
Sentiment: Negative
View Wiseek Article
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets